IMMUNIC, INC. — Director's Dealing 2015

Jul 15, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: VITAL THERAPIES INC (VTL)
CIK: 0001280776
Period of Report: 2015-07-14

Reporting Person: Cohen Cheryl (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-07-14	Stock Option (right to buy)	$26.71	A	12581	Acquired	2025-07-13	Common Stock (12581)	Direct

Footnotes

F1: Subject to reporting person's continuing to be a Service Provider (as defined in the 2014 Equity Incentive Plan) through each vesting date, the shares subject to the option shall vest and become exercisable monthly in forty-eight (48) equal installments. The vesting commencement date for this option is July 14, 2015.